2013
DOI: 10.1016/j.cellsig.2013.08.028
|View full text |Cite
|
Sign up to set email alerts
|

Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial–mesenchymal transition and stemness

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
85
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 104 publications
(88 citation statements)
references
References 53 publications
3
85
0
Order By: Relevance
“…In contrast, ZEB2 expression is significantly higher in infiltrating carcinoma than high-grade urothelial carcinoma [24]. It has been suggested that ZEB1 expression is regulated by nuclear β -catenin upon stimulation [49]. In bladder cancer, β -catenin signaling cascades can be activated by various routes.…”
Section: Bladder and Renal Cancermentioning
confidence: 99%
See 1 more Smart Citation
“…In contrast, ZEB2 expression is significantly higher in infiltrating carcinoma than high-grade urothelial carcinoma [24]. It has been suggested that ZEB1 expression is regulated by nuclear β -catenin upon stimulation [49]. In bladder cancer, β -catenin signaling cascades can be activated by various routes.…”
Section: Bladder and Renal Cancermentioning
confidence: 99%
“…In bladder cancer, β -catenin signaling cascades can be activated by various routes. In which, many evidence pointed to the glycogen synthase kinase 3 β - (GSK3 β -) ZEB1 cascade which was triggered through phosphatidylinositol 3-kinase (PI3 K)/Akt pathways [4951]. Further, noncoding RNA including microRNA-23b and long noncoding RNA MALAT-1 has also been suggested to be the transcriptional regulator of ZEB1 and ZEB2 in bladder cancers [52, 53].…”
Section: Bladder and Renal Cancermentioning
confidence: 99%
“…Thus, CD44 is thought to be a biomarker for cancer stem cells (CSCs) [47]. Functional studies have shown that CD44 is involved in tumorigenesis and metastasis in many cancer types such as colon [4850], bladder [51], gastric [52], breast, [53], and GBM [54]. Recently, overexpression of CD44 was associated with significantly worse overall survival in breast cancer patients [55].…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have found that SIL has strong antitumor activities toward a variety of epithelium-derived tumors, such as prostate,2 colon,1 bladder,13 breast,14 ovarian,15 and lung cancers 3,4. This study analyzed the impacts of SIL on the proliferation of ACC-M cells, and the results revealed that SIL could inhibit the proliferation of ACC-M cells in time- and dose-dependent manner, particularly when treated with 160 µg/mL of SIL for 72 hours, the inhibition rate of 93% suggested that SIL had significant inhibitory activities toward ACC.…”
Section: Discussionmentioning
confidence: 99%